Assembly Biosciences, Inc. (ASMB)

Assembly Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	23.41	38.34	19.84	52.42	45.63	59.44
Short-Term Investments	67.62	73.74	110.41	39.19	101	156.97
Cash & Short-Term Investments	91.03	112.08	130.25	91.61	146.63	216.41
Cash Growth	-19.43%	-13.95%	42.18%	-37.52%	-32.25%	-21.03%
Accounts Receivable	-	-	0.04	0.94	0.34	1.23
Other Receivables	-	0.4	0.3	0.3	-	-
Receivables	-	0.4	0.34	1.24	0.34	1.23
Prepaid Expenses	4.5	3.02	3.2	4.11	7.24	6.85
Total Current Assets	95.53	115.5	133.79	96.97	154.2	224.49
Property, Plant & Equipment	3.18	3.35	2.72	3.94	7.18	10.73
Long-Term Investments	-	-	-	-	27.97	-
Goodwill	-	-	-	-	-	12.64
Other Intangible Assets	-	-	-	-	-	29
Long-Term Deferred Charges	-	-	-	0.2	0.2	0.8
Other Long-Term Assets	0.31	0.31	0.31	0.69	1.5	5.59
Total Assets	99.02	119.17	136.82	101.79	191.06	283.25
Accounts Payable	0.88	0.59	0.46	2.49	2.66	4.6
Accrued Expenses	4.41	9.14	6.63	9.84	10.26	12.27
Current Portion of Leases	0.53	0.46	1.22	3.36	3.15	3.4
Current Unearned Revenue	40.82	37.62	30.92	-	-	-
Other Current Liabilities	-	-	-	0.6	-	4.16
Total Current Liabilities	46.63	47.8	39.23	16.3	16.07	24.43
Long-Term Leases	2.49	2.63	1.12	0.1	3.33	6.73
Long-Term Unearned Revenue	22.76	35.38	55.38	2.73	2.73	8.99
Long-Term Deferred Tax Liabilities	-	-	-	-	-	2.53
Total Liabilities	71.88	85.81	95.73	19.13	22.13	42.68
Common Stock	0.01	0.01	0.01	0	0.05	0.03
Additional Paid-In Capital	862.12	859.49	826.92	807.98	800.73	742.39
Retained Earnings	-834.74	-825.93	-785.75	-724.52	-631.43	-501.57
Comprehensive Income & Other	-0.25	-0.21	-0.08	-0.8	-0.42	-0.27
Shareholders' Equity	27.13	33.36	41.1	82.66	168.93	240.58
Total Liabilities & Equity	99.02	119.17	136.82	101.79	191.06	283.25
Total Debt	3.02	3.09	2.34	3.47	6.48	10.13
Net Cash (Debt)	88.01	108.99	127.91	88.15	168.12	206.28
Net Cash Growth	-20.74%	-14.79%	45.11%	-47.57%	-18.50%	-21.20%
Net Cash Per Share	13.52	18.15	27.94	21.85	46.61	69.87
Filing Date Shares Outstanding	7.64	7.5	5.48	4.33	4.01	3.19
Total Common Shares Outstanding	7.62	7.46	5.48	4.07	4.01	2.84
Working Capital	48.9	67.7	94.56	80.67	138.13	200.06
Book Value Per Share	3.56	4.47	7.50	20.29	42.13	84.84
Tangible Book Value	27.13	33.36	41.1	82.66	168.93	198.94
Tangible Book Value Per Share	3.56	4.47	7.50	20.29	42.13	70.16
Machinery	-	-	-	0.8	0.72	0.95
Leasehold Improvements	-	-	-	1.63	1.63	2.49

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q